Synchron

Synchron

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.synchron.com

Last Round

Series D

Nov 6, 2025

Total Funding Raised

$325M

Company Overview

Synchron is a neurotechnology company that develops an implantable brain-computer interface to interpret brain signals for treating conditions like paralysis, epilepsy, and movement disorders through a minimally invasive device.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Medical AI, Sensors, Biotechnology

Business Model

B2B2C

Customer Profile

Hardware Sales, Government Contracts, Hardware + Subscription, Services & Consulting

AI Layer

Infrastructure

Keywords

brain-computer interfaceBCIendovascular BCIStentrodebrain implantminimally invasive BCIthought controlneurotechnologyassistive technologyneural signal decodingparalysis treatmentcognitive AIendovascular procedurebrainOSbreakthrough device designation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synchron Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synchron Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DNov 6, 2025
Series CDec 15, 2022
Series BJun 3, 2021
Series AApr 4, 2017

Key People

Founding team and executive leadership

Thomas Oxley

CEO

Executive Team

Synchron Investors

Notable investors and investment history

InvestorRounds
Forepont Capital PartnersSeries B, Series C
Greenoaks Capital PartnersSeries C
Khosla VenturesSeries C, Series D, Series B
U.S. Department of DefenseSeries A
Bezos ExpeditionsSeries C, Series D
re.Mind CapitalSeries B
T.Rx CapitalSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2026

    Named to Fast Company's Most Innovative Companies list.

  • Mar 24, 2026

    Named to Fast Company's Most Innovative Companies list for 2026.

Synchron Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synchron Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synchron's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range124
Year Founded2016
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.